Medtech stocks hurt by overall market slide

Singapore

THE medtech industry, as represented by the listed stocks on the Singapore Exchange (SGX), has been hurt by market volatility despite the bubbling prospects of the sector.

The five Singapore-listed stocks that are part of the healthcare equipment and supplies industry, which now include the latest medtech listing Biolidics have generated an average one-year total return of negative 10 per cent. This, however, is in line with the total one-year return of about negative 10.5 per cent of the Straits Times Index, data from Bloomberg showed.